ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Perspective Therapeutics Inc

Perspective Therapeutics Inc (CATX)

2,92
-0,04
(-1,35%)
Fermé 20 Février 10:00PM
2,98
0,06
( 2,05% )
Avant marché: 2:34PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
2,98
Prix Achat
-
Prix Vente
-
Volume échangé
1 028
0,00 Fourchette du Jour 0,00
2,70 Plage de 52 semaines 19,05
Cap du marché
Clôture Veille
2,92
Ouverture
-
Dernière Transaction
10
@
2.99
Dernière heure de transaction
14:58:33
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 047 471
Actions en circulation
67 587 540
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,24
Bénéfice par action (BPA)
-0,69
Chiffre d'affairess
1,43M
Bénéfice net
-46,51M

À propos de Perspective Therapeutics Inc

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more

Secteur
Eating Places
Industrie
Surgical,med Instr,apparatus
Siège social
Wilmington, Delaware, USA
Fondé
1983
Perspective Therapeutics Inc est coté dans le secteur Eating Places de la American Stock Exchange avec le ticker CATX. Le dernier cours de clôture d'Perspective Therapeutics était de US$2,92. Au cours de la dernière année, les actions de Perspective Therapeutics ont été négociées dans une fourchette de prix de US$ 2,70 à US$ 19,05.

Perspective Therapeutics compte actuellement 67 587 540 actions en circulation. La capitalisation boursière d'Perspective Therapeutics est de US$197,36 million. Perspective Therapeutics a un ratio cours/bénéfice (ratio PE) de -4.24.

CATX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.09-2.931596091213.073.212.914400363.00891061CS
4-0.66-18.13186813193.644.242.917056293.50924319CS
12-1.17-28.19277108434.154.522.710474713.45303453CS
26-11.22-79.01408450714.216.552.711987087.06370513CS
52-5.839-66.20932078478.81919.052.7244978212.28743258CS
156-0.783-20.80786606433.76319.052.05167698210.38955501CS
260-0.783-20.80786606433.76319.052.05167698210.38955501CS

CATX - Frequently Asked Questions (FAQ)

What is the current Perspective Therapeutics share price?
The current share price of Perspective Therapeutics is US$ 2,98
How many Perspective Therapeutics shares are in issue?
Perspective Therapeutics has 67 587 540 shares in issue
What is the market cap of Perspective Therapeutics?
The market capitalisation of Perspective Therapeutics is USD 197,36M
What is the 1 year trading range for Perspective Therapeutics share price?
Perspective Therapeutics has traded in the range of US$ 2,70 to US$ 19,05 during the past year
What is the PE ratio of Perspective Therapeutics?
The price to earnings ratio of Perspective Therapeutics is -4,24
What is the cash to sales ratio of Perspective Therapeutics?
The cash to sales ratio of Perspective Therapeutics is 137,74
What is the reporting currency for Perspective Therapeutics?
Perspective Therapeutics reports financial results in USD
What is the latest annual turnover for Perspective Therapeutics?
The latest annual turnover of Perspective Therapeutics is USD 1,43M
What is the latest annual profit for Perspective Therapeutics?
The latest annual profit of Perspective Therapeutics is USD -46,51M
What is the registered address of Perspective Therapeutics?
The registered address for Perspective Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Perspective Therapeutics website address?
The website address for Perspective Therapeutics is perspectivetherapeutics.com
Which industry sector does Perspective Therapeutics operate in?
Perspective Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BITCBitwise Trendwise Bitcoin and Treasuries Rotation Strategy ETF
US$ 59,99
(34,99%)
13
CVMCel Sci Corporation New
US$ 0,5968
(16,40%)
3,48M
XTNTXtant Medical Holdings Inc
US$ 0,6917
(15,18%)
530
IBUYAmplify Online Retail
US$ 84,86
(15,14%)
2
SZKProShares UltraShort Consumer Staples
US$ 13,00
(8,38%)
150
ATMPiPath Select MLP ETN
US$ 18,01
(-41,49%)
3
DITAMCON Distributing Co
US$ 115,00
(-12,55%)
578
LGLLGL Group Inc
US$ 6,07
(-12,03%)
8
FRDFriedman Industries Inc
US$ 14,85
(-12,03%)
9
CVNYYieldmax Cvna Option Income Strategy ETF
US$ 50,69
(-10,44%)
4
FXIiShares China Large Cap
US$ 35,61
(1,60%)
3,74M
CVMCel Sci Corporation New
US$ 0,5968
(16,40%)
3,48M
KWEBKraneShares CSI China Internet
US$ 35,97
(2,83%)
2,5M
KOLDProShares UltraShort Bloomberg Natural Gas
US$ 21,01
(6,11%)
2,25M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 31,96
(1,56%)
2,13M
Aucune Discussion Trouvée
Ajouter une Discussion